Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival

International Journal of Colorectal Disease

Volumn 25, Issue 5, 2010, Pages 573-581

  Doll, Dietrich ^a,b   Keller, Larissa ^a   Maak, Matthias ^a   Boulesteix, Anne Laure ^c   Siewert, Jörg R ^a,d   Holzmann, Bernhard ^a   Janssen, Klaus Peter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 8;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL STRAIN CACO 2; CELL STRAIN HCT116; CELL STRAIN HT29; COLON ADENOMA; COLON MUCOSA; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CHEMOKINE CXCL2; CHEMOKINES, CXC; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 77953288700     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-0901-1     Document Type: Article

References (45)

1. Friederichs J, Rosenberg R, Mages J, Janssen KP, Maeckl C, Nekarda H, Holzmann B, Siewert JR (2005) Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int J Colorectal Dis 20:391-402
2. Vandercappellen J, Van DJ, Struyf S (2008) The role of CXC chemokines and their receptors in cancer. Cancer Lett 267:226-244
3. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M (2005) Chemokines in tumor progression and metastasis. Cancer Sci 96:317-322
4. Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, Kunkel SL (1992) Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 141:397-407
5. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C, Jacobson K, Weinstein DL, Metcalf EL, Pollard HB (2001) Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Mol Med 7:523-534
6. Wuyts A, Van ON, Haelens A, Samson I, Herdewijn P, Ben-Baruch A, Oppenheim JJ, Proost P, Van DJ (1997) Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 36:2716-2723
7. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847-855
8. Li A, Varney ML, Singh RK (2001) Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 7:3298-3304
9. Shi Q, Abbruzzese JL, Huang S, Fidler IJ, Xiong Q, Xie K (1999) Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5:3711-3721
10. Singh RK, Varney ML, Bucana CD, Johansson SL (1999) Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin. Melanoma Res 9:383-387
11. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP (2000) Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 60:2290-2299 (Pubitemid 30225196)
12. Zhu YM, Webster SJ, Flower D, Woll PJ (2004) Interleukin-8/ CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 91:1970-1976
13. Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, Yamamoto S, Sumii K, Kajiyama G, Fidler IJ, Tahara E (2000) Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res 6:2735-2740
14. LI A, Varney ML, Singh RK (2004) Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype. Clin Exp Metastasis 21:571-579
15. Wang X, Wang Q, Ives KL, Evers BM (2006) Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res 12:5346-5355
16. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78-85
17. Ueda T, Shimada E, Urakawa T (1994) Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423-429
18. Rubie C, Frick VO, Pfeil S, Wagner M, Kollmar O, Kopp B, Graber S, Rau BM, Schilling MK (2007) Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 13:4996-5002
19. Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U, Hopt UT (2005) Chemokines in human colorectal carcinoma. Anticancer Res 25:3581-3584
20. Yang SK, Eckmann L, Panja A, Kagnoff MF (1997) Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113:1214-1223
21. Chung YC, Chang YF (2003) Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology 50:1910-1913
22. Richmond A, Thomas HG (1988) Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185-198
23. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van DJ, Walz A, Marriott D (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357
24. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165:5269-5277
25. Tebo J, Der S, Frevel M, Khabar KS, Williams BR, Hamilton TA (2003) Heterogeneity in control of mRNA stability by AU-rich elements. J Biol Chem 278:12085-12093
26. Cuenca RE, Azizkhan RG, Haskill S (1992) Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement. Surg Oncol 1:323-329
27. Cao Y, Chen C, Weatherbee JA, Tsang M, Folkman J (1995) grobeta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 182:2069-2077
28. Gupta V, Yeo G, Kawakubo H, Rangnekar V, Ramaswamy P, Hayashida T, MacLaughlin DT, Donahoe PK, Maheswaran S (2007) Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Cancer Res 67:2747-2756
29. Bieche I, Chavey C, Andrieu C, Busson M, Vacher S, Le CL, Guinebretiere JM, Burlinchon S, Lidereau R, Lazennec G (2007) CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer 14:1039-1052
30. Wen Y, Giardina SF, Hamming D, Greenman J, Zachariah E, Bacolod MD, Liu H, Shia J, Amenta PS, Barany F, Paty P, Gerald W, Notterman D (2006) GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res 12:5951-5959
31. Hothorn T, Hornik K, Van de Wiel MA, Zeileis A (2006) A Lego system for conditional inference. Am Stat 60:257-263
32. Moore BB, Arenberg DA, Addison CL, Keane MP, Strieter RM (1998) Tumor angiogenesis is regulated by CXC chemokines. J Lab Clin Med 132:97-103
33. Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM (1997) The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol 62:554-562
34. Strieter RM, Addison CL, Ehlert JE, Keane MP, Belperio JA, Burdick MD, Arenberg DA (1999) Use of immunodeficient mice for the evaluation of CXC chemokines in the regulation of tumor-associated angiogenesis. ILAR J 40:175-182
35. Rosenkilde MM, Schwartz TW (2004) The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 112:481-495
36. Janssen KP, el-Marjou F, Pinto D, Sastre X, Rouillard D, Fouquet C, Soussi T, Louvard D, Robine S (2002) Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 123:492-504
37. Desbaillets I, Diserens AC, Tribolet N, Hamou MF, Van Meir EG (1997) Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186:1201-1212
38. Sager R, Anisowicz A, Pike MC, Beckmann P, Smith T (1992) Structural, regulatory, and functional studies of the GRO gene and protein. Cytokines 4:96-116
39. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, Arditi M (2002) TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 277:20431-20437
40. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C (2007) Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 14:1712-1717
41. Chiu ST, Hsieh FJ, Chen SW, Chen CL, Shu HF, Li H (2005) Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer. Cancer Epidemiol Biomarkers Prev 14:437-443
42. Hensley C, Spitzler S, McAlpine BE, Lynn M, Ansel JC, Solomon AR, Armstrong CA (1998) In vivo human melanoma cytokine production: inverse correlation of GM-CSF production with tumor depth. Exp Dermatol 7:335-341
43. Lejeune P, Reisser D, Onier N, Lagadec P, Lindley I, Jeannin JF 1994 Interleukin-8 has antitumor effects in the rat which are not associated with polymorphonuclear leukocyte cytotoxicity. Cancer Immunol Immunother 38:167-170
44. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP (1999) Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res 5:783-789
45. Scheibenbogen C, Mohler T, Haefele J, Hunstein W, Keilholz U 1995 Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res 5:179-181